Study on Immunogenicity and Safety of a Meningococcal ACYW Conjugate Vaccine in Healthy Infants and Toddlers

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

840

Participants

Timeline

Start Date

March 19, 2024

Primary Completion Date

October 3, 2025

Study Completion Date

October 3, 2025

Conditions
Meningococcal ImmunisationHealthy Volunteers
Interventions
BIOLOGICAL

MenACYW conjugate vaccine

Pharmaceutical form:Solution for injection (in a single-dose vial)-Route of administration:Intramuscular (IM) injection

BIOLOGICAL

MenACYW conjugate vaccine

Pharmaceutical form:Solution for injection (powder or cake in a single dose glass vial and a clear and colourless solvent in a pre filled syringe for reconstitution-Route of administration:Intramuscular (IM) injection

Trial Locations (45)

9800

Investigational Site Number : 2080005, Hjørring

67100

Investigational Site Number : 2460003, Kokkola

67550

Investigational Site Number : 2760009, Worms

370 06

Investigational Site Number : 2030002, České Budějovice

Unknown

Investigational Site Number: 2030001, České Budějovice

Investigational Site Number: 2030005, Prague

Investigational Site Number: 2080007, Aalborg

Investigational Site Number: 2080004, Aarhus

Investigational Site Number: 2080006, Herlev

Investigational Site Number: 2080002, Odense

Investigational Site Number: 2080001, Zeeland

Investigational Site Number: 2460005, Espoo

Investigational Site Number: 2460002, Helsinki

Investigational Site Number: 2460011, Helsinki

Investigational Site Number: 2460006, Jaarvenpa

Investigational Site Number: 2460007, Oulu

Investigational Site Number: 2460004, Tampere

Investigational Site Number: 2460012, Turku

Investigational Site Number: 2760007, Erfurt

Investigational Site Number: 2760004, Herxheim

Investigational Site Number: 2760003, Hürth

Investigational Site Number: 2760001, Mönchengladbach

Investigational Site Number: 2760011, Mönchengladbach

Investigational Site Number: 2760005, Schönau am Königssee

Investigational Site Number: 2760008, Schweigen-Rechtenbach

Investigational Site Number: 2760010, Wolfsburg

Investigational Site Number: 6160003, Bydgoszcz

Investigational Site Number: 6160008, Bydgoszcz

Investigational Site Number: 6160017, Bydgoszcz

Investigational Site Number: 6160015, Krakow

Investigational Site Number: 6160021, Krakow

Investigational Site Number: 6160012, Luboń

Investigational Site Number: 6160011, Siemianowice Śląskie

Investigational Site Number: 6160007, Torun

Investigational Site Number: 6160014, Trzebnica

Investigational Site Number: 6160022, Warsaw

Investigational Site Number: 6160010, Wroclav

Investigational Site Number: 6160002, Wroclaw

Investigational Site Number: 6160016, Łęczna

Investigational Site Number: 6160004, Łomianki

Investigational Site Number: 6420002, Bucharest

Investigational Site Number: 6420005, Călăraşi

85-079

Investigational Site Number : 6160001, Bydgoszcz

011025

Investigational Site Number : 6420001, Bucharest

021105

Investigational Site Number : 6420003, Bucharest

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY